Original version

BBC World Service Europe and the Middle East

The Evidence

Factual: Science & Nature

Factual: Science & Nature: Science & Technology

Claudia Hammond joins scientists and experts to explore science’s effect on our world

Claudia Hammond joins scientists and experts to explore the effect science has on the world around us

BBC World Service schedule for American satellite radio and the Caribbean

BBC World Service Americas and the Caribbean

BBC World Service Australasia

BBC World Service

BBC World Service East and Southern Africa Schedule

BBC World Service East and Southern Africa

BBC World Service News Internet

BBC World Service South Asia

BBC World Service Online

BBC World Service West and Central Africa Schedule

BBC World Service West and Central Africa

BBC World Service East Asia

The Evidence: Coronavirus: The Evidence: The Shapeshifting Virus

Discussion & Talk

News

Mutating coronavirus

30/01/2021 GMT

The Shapeshifting Virus

Coronavirus: The Evidence

BBC World Service - The Evidence, Coronavirus: The Evidence, The Shapeshifting VirusSearch BBC

Will new vaccines work against the more infectious versions of the coronavirus?

When does a mutation become a new variant; will new vaccines work against the new versions identified in South Africa, the UK and Brazil; is herd immunity still possible?

News that at least three new variants of SARS-CoV-2 have emerged in three separate continents have sent a chill throughout the scientific community. All viruses mutate but the speed and scale of the changes and the fact they occurred independently, is seen as a wake-up call.

Genetic sequencing in South Africa first raised the alarm about the version of the virus that was racing through populations in the Eastern and then Western Cape. 

Scientists at the country’s KwaZulu-Natal Research and Innovation Sequencing Platform, KRISP, were struck by the sheer number of genetic mutations, many of which were on the all-important spike protein. This is where the virus binds to human cells and where neutralising antibodies, our immune system’s defences, also mount their defence. Any changes there, researchers knew, could be bad news.

Genetic sequencers in the UK also identified a new lineage which shares just some of the mutations in the South African variant. Named B.1.1.7 this version tore through populations in the South East of England and is now the dominant strain throughout the country and beyond. Latest estimates suggest is between 30 and 50% more infectious, although exactly how it is more transmissible is still being worked out.

In Brazil too, news earlier this month of another troubling variant, the P.1. tearing through populations in Manaus, the capital of Brazil’s Amazonas state, where so many were infected in the first wave of the pandemic. Like the version identified in South Africa, this variant also has mutation called E484K on the all-important spike protein. This could make the virus better at evading antibodies, with huge implications for re-infection rates and the new vaccines.

Claudia Hammond and her expert panel consider what the new shapeshifting virus means for the global goal of herd immunity and an end to the pandemic. And they answer your questions. Please do keep your virus queries coming in to the.evidence@bbc.co.uk and your question could be included in the next programme.

Claudia’s guests include Dr Richard Lessells, infectious diseases specialist from the University of KwaZulu-Natal in South Africa and part of the team that identified the South African variant; Dr Muge Cevik, clinical lecturer in infectious diseases and medical virology at the University of St Andrews in Scotland and a member of the UK’s expert committee NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group); Dr Shane Crotty, Professor for Infectious Disease and Vaccine Research at la Jolla Institute for Immunology, University of California San Diego in the USA and Dr Margaret Harris from the World Health Organisation in Geneva. 

Produced by: Fiona Hill, Samara Linton and Maria Simons
Editor: Deborah Cohen
Technical Support: Donald McDonald and Tim Heffer

The Evidence: Coronavirus: The Evidence

Magazines & Reviews

Claudia Hammond is joined by experts to answer questions about the coronavirus Covid-19.

In The Evidence Claudia Hammond is joined by an expert scientific panel to answer questions from the audience on a variety of aspects of the coronavirus and Covid 19, from the impact of lockdowns and self isolation on the spread of the disease, to the question of who should be tested and the search for treatments. 
Professor Vivek Jha, Executive Director, of the George Institute for Global Health, India, talks about the situation in his country where a lockdown was announced four hours before it began.

Dr Lyndsey Broadbent, a virologist at Queens University Belfast in Northern Ireland, explains what is now known about the biology of the virus and why it causes serious disease in some people and no symptoms in others. 
Christos Lynteris, a medical anthropologist from St Andrews University, discusses the issue of stigma that’s being experienced by some people who have had Covid-19. 

Claudia also hears from a psychiatrist at the University of Verona in northern Italy, which has taken the brunt of cases in the country about some of the most serious consequences for doctors and nurses, and the general population.

Accessibility links

Programme Index

The Evidence

Coronavirus: The Evidence

The Shapeshifting Virus

Genres

Formats

Brand

Series

BBC World Service Europe and the Middle East

About BBC World Service